title: Yeast as an expression system for producing virus-like particles: what factors do we need to consider?
abstract: The development of various types of virus-like particles (VLPs) has accelerated over the past two decades as the importance of VLPs for generating next-generation vaccines has been appreciated. Yeast has advantages such as scalable fermentation, low risk of contamination by adventitious agents, low production costs and the ability to produce VLPs with reliable qualities. It is generally recognized that yeast is suitable for producing VLPs that have simple structures and are produced intracellularly. However, recently there has been much effort to extend its applicability, and there is now evidence that it can be used as an expression platform for the productions of VLPs not only of nonenveloped viruses but also of enveloped viruses. Moreover, evidences indicated that yeast allows secretory VLP productions. Meanwhile, it has become evident that the quality and quantity of yeast-derived VLPs are influenced by the choice of plasmid and promoter, the ratio of the structural proteins produced. Here, we review the characteristics of the yeast expression system in terms of the production of VLP and compare it with other expression systems. We also consider strategies for VLP production in yeast and factors that need to be taken into account.
authors.affiliation: Laboratory of Virology, College of Pharmacy, Chung-Ang University, Seoul, South Korea.
authors.forename: H J
authors.initials: HJ
authors.lastname: Kim
authors.affiliation: Laboratory of Virology, College of Pharmacy, Chung-Ang University, Seoul, South Korea.
authors.forename: H-J
authors.initials: HJ
authors.lastname: Kim
mesh_terms: D000818:Animals; D015870:Gene Expression; D006801:Humans; D012441:Saccharomyces cerevisiae / Q000235:genetics / Q000378:metabolism*; D058425:Vaccines, Virus-Like Particle / Q000096:biosynthesis*; D015678:Viral Structural Proteins / Q000096:biosynthesis*
chemical_list: D058425:Vaccines, Virus-Like Particle; D015678:Viral Structural Proteins
keywords: enveloped virus; nonenveloped virus; vaccine; virus-like particles; yeast